Literature DB >> 25968061

Vestibular Dysfunction in Patients with Enlarged Vestibular Aqueduct.

Chris K Zalewski1, Wade W Chien2, Kelly A King1, Julie A Muskett1, Rachel E Baron1, John A Butman3, Andrew J Griffith4, Carmen C Brewer1.   

Abstract

OBJECTIVE: Enlarged vestibular aqueduct (EVA) is the most common inner ear malformation. While a strong correlative relationship between EVA and hearing loss is well established, its association with vestibular dysfunction is less well understood. In this study, we examine the effects of EVA on the vestibular system in patients with EVA. STUDY
DESIGN: Prospective, cross-sectional study of a cohort ascertained between 1999 and 2013.
SETTING: National Institutes of Health Clinical Center, a federal biomedical research facility. SUBJECTS AND METHODS: In total, 106 patients with unilateral or bilateral EVA, defined as a midpoint diameter greater than 1.5 mm, were referred or self-referred to participate in a study of the clinical and molecular aspects of EVA. Clinical history was ascertained with respect to the presence or absence of various vestibular signs and symptoms and history of head trauma. Videonystagmography (VNG), cervical vestibular evoked myogenic potential (cVEMP), and rotational vestibular testing (RVT) were performed to assess the vestibular function.
RESULTS: Of the patients with EVA, 45% had vestibular signs and symptoms, and 44% of tested patients had abnormal VNG test results. An increased number of vestibular signs and symptoms was correlated with the presence of bilateral EVA (P = .008) and a history of head injury (P < .001). Abnormal VNG results also correlated with a history of head injury (P = .018).
CONCLUSION: Vestibular dysfunction is common in patients with EVA. However, not all patients with vestibular signs and symptoms have abnormal vestibular test results. Clinicians should be aware of the high prevalence of vestibular dysfunction in patients with EVA. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2015.

Entities:  

Keywords:  EVA; LVAS; RVT; VEMP; VNG; dizziness; enlarged vestibular aqueduct; hearing loss; vertigo; vestibular dysfunction

Mesh:

Year:  2015        PMID: 25968061      PMCID: PMC8010515          DOI: 10.1177/0194599815585098

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  31 in total

1.  Serial MR imaging studies in enlarged endolymphatic duct and sac syndrome.

Authors:  Shinji Naganawa; Tokiko Koshikawa; Hiroshi Fukatsu; Takeo Ishigaki; Tsutomu Nakashima
Journal:  Eur Radiol       Date:  2002-06-21       Impact factor: 5.315

2.  SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations.

Authors:  Sébastien Albert; Hélène Blons; Laurence Jonard; Delphine Feldmann; Pierre Chauvin; Nathalie Loundon; Annie Sergent-Allaoui; Muriel Houang; Alain Joannard; Sébastien Schmerber; Bruno Delobel; Jacques Leman; Hubert Journel; Hélène Catros; Hélène Dollfus; Marie-Madeleine Eliot; Albert David; Catherine Calais; Valérie Drouin-Garraud; Marie-Françoise Obstoy; Patrice Tran Ba Huy; Didier Lacombe; Françoise Duriez; Christine Francannet; Pierre Bitoun; Christine Petit; Eréa-Noël Garabédian; Rémy Couderc; Sandrine Marlin; Françoise Denoyelle
Journal:  Eur J Hum Genet       Date:  2006-06       Impact factor: 4.246

3.  Air-bone gap and resonant frequency in large vestibular aqueduct syndrome.

Authors:  T Nakashima; H Ueda; A Furuhashi; E Sato; K Asahi; S Naganawa; R Beppu
Journal:  Am J Otol       Date:  2000-09

4.  Magnetic resonance imaging of patients with large vestibular aqueducts.

Authors:  T Okumura; H Takahashi; I Honjo; A Takagi; R Azato
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

5.  Use of SLC26A4 mutation testing for unilateral enlargement of the vestibular aqueduct.

Authors:  Parna Chattaraj; Fabian R Reimold; Julie A Muskett; Boris E Shmukler; Wade W Chien; Anne C Madeo; Shannon P Pryor; Christopher K Zalewski; John A Butman; Carmen C Brewer; Margaret A Kenna; Seth L Alper; Andrew J Griffith
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-09       Impact factor: 6.223

6.  Vestibular function in patients with a large vestibular aqueduct.

Authors:  T Okumura; H Takahashi; I Honjo; Y Naito; A Takagi; J Tuji; J Ito
Journal:  Acta Otolaryngol Suppl       Date:  1995

7.  Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS).

Authors:  L A Everett; B Glaser; J C Beck; J R Idol; A Buchs; M Heyman; F Adawi; E Hazani; E Nassir; A D Baxevanis; V C Sheffield; E D Green
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

8.  Enlarged vestibular aqueduct syndrome in the pediatric population.

Authors:  Colm Madden; Mark Halsted; Corning Benton; John Greinwald; Daniel Choo
Journal:  Otol Neurotol       Date:  2003-07       Impact factor: 2.311

9.  Vestibular-evoked myogenic potentials in three patients with large vestibular aqueduct.

Authors:  Kianoush Sheykholeslami; Sébastien Schmerber; Mohammad Habiby Kermany; Kimitaka Kaga
Journal:  Hear Res       Date:  2004-04       Impact factor: 3.208

10.  Airway obstruction in the Pierre Robin sequence.

Authors:  S M Tomaski; G H Zalzal; H M Saal
Journal:  Laryngoscope       Date:  1995-02       Impact factor: 3.325

View more
  10 in total

1.  Functional Testing of SLC26A4 Variants-Clinical and Molecular Analysis of a Cohort with Enlarged Vestibular Aqueduct from Austria.

Authors:  Sebastian Roesch; Emanuele Bernardinelli; Charity Nofziger; Miklós Tóth; Wolfgang Patsch; Gerd Rasp; Markus Paulmichl; Silvia Dossena
Journal:  Int J Mol Sci       Date:  2018-01-10       Impact factor: 5.923

2.  Unilateral Enlarged Vestibular Aqueduct Syndrome and Bilateral Endolymphatic Hydrops.

Authors:  Massimo Ralli; Giuseppe Nola; Luca Sparvoli; Giovanni Ralli
Journal:  Case Rep Otolaryngol       Date:  2017-05-18

3.  Influence of Cochlear Implantation on Vestibular Function in Children With an Enlarged Vestibular Aqueduct.

Authors:  Ruijie Wang; Daogong Zhang; Jianfen Luo; Xiuhua Chao; Jiliang Xu; Xianfeng Liu; Zhaomin Fan; Haibo Wang; Lei Xu
Journal:  Front Neurol       Date:  2021-04-21       Impact factor: 4.003

4.  Normative data for ages 18-45 for ocular motor and vestibular testing using eye tracking.

Authors:  Aura Kullmann; Robin C Ashmore; Alexandr Braverman; Christian Mazur; Hillary Snapp; Erin Williams; Mikhaylo Szczupak; Sara Murphy; Kathryn Marshall; James Crawford; Carey D Balaban; Michael Hoffer; Alexander Kiderman
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-08-21

5.  Objective vestibular function changes in children following cochlear implantation.

Authors:  Ruijie Wang; Xiuhua Chao; Jianfen Luo; Daogong Zhang; Jiliang Xu; Xianfeng Liu; Zhaomin Fan; Haibo Wang; Lei Xu
Journal:  J Vestib Res       Date:  2022       Impact factor: 2.354

6.  Genetic screening revealed usher syndrome in a paediatric Chinese patient.

Authors:  Chunyan Qu; Fenghe Liang; Qin Long; Min Zhao; Haiqiong Shang; Lynn Fan; Li Wang; Joseph Foster; Denise Yan; Xuezhong Liu
Journal:  Hearing Balance Commun       Date:  2017-05-04

Review 7.  Genetic architecture and phenotypic landscape of SLC26A4-related hearing loss.

Authors:  Keiji Honda; Andrew J Griffith
Journal:  Hum Genet       Date:  2021-08-03       Impact factor: 4.132

Review 8.  Diagnostic Value of SLC26A4 Mutation Status in Hereditary Hearing Loss With EVA: A PRISMA-Compliant Meta-Analysis.

Authors:  Ya-Jie Lu; Jun Yao; Qin-Jun Wei; Guang-Qian Xing; Xin Cao
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

9.  Clinically relevant human temporal bone measurements using novel high-resolution cone-beam CT.

Authors:  Jing Zou; Jaakko Lähelmä; Antti Arnisalo; Ilmari Pyykkö
Journal:  J Otol       Date:  2017-01-19

Review 10.  Understanding the Pathophysiology of Congenital Vestibular Disorders: Current Challenges and Future Directions.

Authors:  Kenna D Peusner; Nina M Bell; June C Hirsch; Mathieu Beraneck; Anastas Popratiloff
Journal:  Front Neurol       Date:  2021-09-10       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.